Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.
about
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in micec-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centersStress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.The role of B lymphocytes in coxsackievirus B3 infection.Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis.Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibilityProtein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses.Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cellsProteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes.Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
P2860
Q24522973-B1221379-3DF9-4172-B0D4-78FB28EB8851Q24804882-00314A04-C994-4AE8-8A98-E7F1B67918C8Q27335025-EF514070-1063-4546-9244-3D5492A23E6EQ27480895-BA9A0320-542E-459B-8561-A03E66FEEFF1Q34124131-976D2303-0623-4B3E-80D5-153DCB4E359EQ34333784-D3133333-3837-4932-9516-1075ECBA32FFQ34345561-82D3B385-0C0F-4B9B-BC29-85EAE8C9CFBAQ35788195-01D4A15E-FF76-4574-87BB-6B499CE45A53Q35826103-B88637ED-2CE6-4A4B-ABD6-7179DD1857FDQ36607055-C0A5F317-581D-4C06-BB30-F9415900DC46Q36990137-1A4BA374-6FA3-4C87-8076-F6E95C7379B5Q37093066-9D1401A5-71E2-4868-9EE9-2E2AF83CC9AAQ37683265-B8A33A65-ACA2-430C-AA83-0A9DA379D4C7Q38090473-EAE1CA8B-785C-478F-9534-C63604C298D7Q38732518-3FB641F3-4F51-417E-8455-A1D5D5696CA9Q39580635-42F0E2D5-AE7B-42A7-B428-FC0F7E9BE770Q42792322-E51931DB-1D33-4463-B998-CA9C610C6CF2Q42847096-1088D09D-6416-442B-9352-72D99466D6C3
P2860
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Direct interactions of coxsack ...... e or resistant to myocarditis.
@en
Direct interactions of coxsack ...... e or resistant to myocarditis.
@nl
type
label
Direct interactions of coxsack ...... e or resistant to myocarditis.
@en
Direct interactions of coxsack ...... e or resistant to myocarditis.
@nl
prefLabel
Direct interactions of coxsack ...... e or resistant to myocarditis.
@en
Direct interactions of coxsack ...... e or resistant to myocarditis.
@nl
P2093
P2860
P1433
P1476
Direct interactions of coxsack ...... e or resistant to myocarditis.
@en
P2093
P2860
P304
P407
P577
1996-07-01T00:00:00Z